Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study by 泥쒖옱�씗
RESEARCH ARTICLE
Clinical Factors and Disease Course Related
to Diagnostic Delay in Korean Crohn’s
Disease Patients: Results from the CONNECT
Study
Chang MoMoon1, Sung-Ae Jung1*, Seong-Eun Kim1, Hyun Joo Song2, Yunho Jung3,
Byong Duk Ye4, Jae Hee Cheon5, You Sun Kim6, Young-Ho Kim7, Joo Sung Kim8, Dong
Soo Han9, CONNECT study group¶
1 Department of Internal Medicine, School of Medicine, EwhaWomans University, Seoul, Republic of Korea,
2 Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Republic of Korea,
3 Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan Hospital,
Cheonan, Republic of Korea, 4 Department of Internal Medicine, University of Ulsan College of Medicine,
Seoul, Republic of Korea, 5 Department of Internal Medicine, Yonsei University College of Medicine, Seoul,
Republic of Korea, 6 Department of Internal Medicine, Inje University College of Medicine, Seoul Paik
Hospital, Seoul, Republic of Korea, 7 Department of Internal Medicine, Sungkyunkwan University School of
Medicine, Seoul, Republic of Korea, 8 Department of Internal Medicine, Seoul National University College of
Medicine, Seoul, Republic of Korea, 9 Department of Internal Medicine, Hanyang University College of
Medicine, Guri Hospital, Guri, Republic of Korea
¶ Membership of the CONNECT study group is listed in the Acknowledgments.
* jassa@ewha.ac.kr
Abstract
Diagnostic delay frequently occurs in Crohn’s disease (CD) patients because of diagnostic
limitations. However, diagnostic delay and its related factors remain poorly defined. There-
fore, we aimed to identify the predictors associated with diagnostic delay and to evaluate
the impact of diagnostic delay on clinical course in a Korean CD patient cohort. We per-
formed a multicenter retrospective analysis of 1,047 CD patients registered in the Crohn’s
Disease Clinical Network and Cohort study in Korea. The mean interval of diagnostic delay
was 16.0 ± 33.1 months. Multivariate analysis showed that older age at diagnosis (40
years) (p = 0.014), concomitant upper gastrointestinal (UGI) disease (p = 0.012) and pene-
trating disease behavior at diagnosis (p = 0.001) were positively associated with long diag-
nostic delay (18 months). During the longitudinal follow-up, long diagnostic delay was
independently predictive of further development of intestinal stenosis (hazard ratio [HR],
1.43; 95% confidence interval [CI], 1.07–1.93; p = 0.017), internal fistulas (HR, 1.62; 95%
CI, 1.12–2.33; p = 0.011), and perianal fistulas (HR, 1.38; 95% CI, 1.06–1.80; p = 0.016).
However, as for the risk of abscess formation, bowel perforation, and CD-related abdominal
surgery, no significant association with diagnostic delay was observed. Older age at diagno-
sis, UGI involvement, and penetrating behavior are associated with long diagnostic delay in
Korean CD patients. Moreover, diagnostic delay is associated with an increased risk of CD-
related complications such as intestinal stenosis, internal fistulas, and perianal fistulas.
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Introduction
Crohn’s disease (CD) is a chronic relapsing and destructive inflammatory condition of the gas-
trointestinal tract that progresses to bowel damage related to impaired functioning. When CD
patients are followed over time, patients with inflammatory behavior tend to experience struc-
tural destruction of the bowel, such as stricture or internal fistulas [1,2]. Recently, studies have
shown that early diagnosis and intensive treatment of CD are necessary to prevent bowel dam-
age and unexpected surgery in patients [3–5]. In addition, studies reported that early intensive
treatment with immunomodulators or biologics showed superior clinical outcomes to conven-
tional treatment in newly diagnosed CD patients [3,4].
However, a long diagnostic delay occurs in a considerable number of CD patients [6,7]
because of the unspecific symptoms of CD and unsatisfactory diagnostic accuracy of tests for
CD. Considering that intestinal inflammation occurs after the onset of the first symptoms in
CD patients, reducing diagnostic delay could have clinical implications in real clinical practice.
Identification of factors associated with CD can allow early treatment and prevent an unfavor-
able course in CD patients. Several studies have evaluated clinical factors associated with diag-
nostic delay in Western patients [8,9] and few studies have examined these factors in Eastern
patients [10]. Considering the significant differences in the epidemiologic and clinical features
of CD according to ethnicities and environmental factors [11–13], diagnostic delay and its
associated factors may differ with countries.
Therefore, the present study aimed to evaluate the clinical factors associated with a long
diagnostic delay in Korean CD patients. In addition, we investigated the influence of diagnostic
delay on the clinical course of CD, including the occurrence of complications, in our CD
patient cohort.
Materials and Methods
Study subjects
This study analyzed clinical data obtained from 1,047 Korean CD patients diagnosed between
January 1, 2000 to December 31, 2008. All data were retrieved from the Crohn’s Disease Clini-
cal Network and Cohort (CONNECT) study, a multicenter retrospective cohort study of CD
patients, which was conducted in 30 university hospitals and 2 local hospitals nationwide in
Korea [14]. All patients were diagnosed and treated by inflammatory bowel disease (IBD) spe-
cialists who are members of the Korean Association for the Study of Intestinal Diseases. Diag-
nosis of CD was made on the basis of clinical, endoscopic, radiological, and histopathologic
characteristics of the patients [15,16]. The following patients were excluded from this study:
those who were diagnosed with or suspected to have intestinal tuberculosis, intestinal Behçet’s
disease, or indeterminate colitis; those who were followed up for< 6 months; and those with
incomplete medical records. Because this is retrospective observational study, written consent
could not be obtained. But, all clinical data were analyzed anonymously to protect patient pri-
vacy. This study was approved by the Institutional Review Board of Ewha Womans University
Mokdong Hospital (EUMC 2014-10-034) and conducted in accordance with the ethical guide-
lines of the Declaration of Helsinki.
Data collection, definition and assessment of clinical outcomes
The demographic and clinical characteristics including age at first diagnosis, gender, family
history of IBD, history of previous abdominal surgery, and follow-up duration were analyzed.
Follow-up duration was defined as the period from the CD diagnosis to the latest follow-up.
Disease location and behavior at initial presentation were classified according to the Montreal
Diagnostic Delay in Korean Crohn's Disease Patients
PLOS ONE | DOI:10.1371/journal.pone.0144390 December 8, 2015 2 / 13
Classification [17]. Prescribed medications including 5-aminosalicylic acid, antibiotics, oral
corticosteroids, azathioprine/6-mercaptopurine, methotrexate, and anti-tumor necrosis factor
α (anti-TNFα) were also recorded. Data were obtained by reviewing the medical records of the
CD patients at each institute. Diagnostic delay was defined as the time interval from the onset
of the first symptoms to the establishment of the CD diagnosis. The first CD-related symptoms
and their onset were evaluated in all patients by a review of the physician’s notes. Specific
symptoms of CD included bloody diarrhea, chronic or recurrent diarrhea or abdominal pain
accompanied by noticeable weight loss, general weakness, and fever. To investigate the associa-
tion between clinical factors and diagnostic delay in CD patients, a time interval of18 months
was defined as a “long diagnostic delay.” Further, to evaluate the clinical effects of the diagnos-
tic delay, the primary outcome was measured as the time to development of the following CD-
related complications: intestinal stenosis, internal fistula, perianal fistula, abscess formation,
bowel perforation, and disease-related abdominal surgery. Internal fistulas included all fistulas
from the bowel to other organs, such as entero-enteric, enterocutaneous, enterovesical, and
enterourinary fistulas, except perianal fistulas. Patients who underwent operation for the treat-
ment of perianal disease and strictureplasty were excluded from the analysis. The diagnostic
delay interval was categorized as follows:<3 months, 3–6 months, 6–18 months, and18
months.
Statistical analysis
We first performed two sets of univariate and multivariate analyses to identify the clinical fac-
tors associated with the long diagnostic delay in CD patients. In these analyses, the dependent
variable was diagnostic delay and the independent variables were as follows: age (<40 or40
years), gender, family history of IBD, any ileal involvement, concomitant upper gastrointestinal
(UGI) disease, and disease behavior at the time of diagnosis. The chi-square or Fisher’s exact
test was used for the univariate analysis and a multiple logistic regression model adjusted for
the aforementioned variables was used for the multivariate analysis.
Further, a Kaplan-Meier survival model and log-rank test were used to evaluate the clinical
variables associated with the outcomes of interest (intestinal stenosis, internal fistula, perianal
fistula, abscess formation, bowel perforation, and CD-related abdominal surgery). In addition,
a multivariate Cox proportional hazards regression analysis including age, gender, family his-
tory of IBD, any ileal involvement, UGI involvement, and the diagnostic delay interval was per-
formed to assess the impact of diagnostic delay on the disease course. Hazard ratios (HRs) and
95% confidence intervals (CIs) were calculated as measures of the correlation between the clini-
cal variables and outcomes of interest. Values of p< 0.05 were considered statistically signifi-
cant. Statistical analyses were performed using SPSS software version 18.0 (SPSS Inc., Chicago,
IL, USA).
Results
Baseline characteristics of patients
This study included 1,047 Korean CD patients. The mean age at first diagnosis was 27.7 ± 12.3
years, and the male-to-female ratio was 2.61:1. Regarding disease location at diagnosis, ileoco-
lonic disease (613 patients, 58.5%) was the most common, and UGI involvement was observed
in 95 (9.1%) patients. Disease behavior was inflammatory in 855 (81.7%), stricturing in 104
(9.9%), and penetrating in 88 (8.4%) patients. Of the patients, 748 (71.4%) were on immuno-
modulators and 304 (29.0%) were prescribed anti-TNFα agents. During the follow-up period,
228 (21.8%) patients underwent abdominal surgery owing to CD-related problems. The mean
length of the diagnostic delay was 16.0 ± 33.1 (range: 0–412.4) months. On the basis of the
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diagnostic delay interval, 471 (45.0%) patients were categorized in<3-month delay group,
whereas 224 (21.4%) patients were categorized in18-month delay group. The mean follow-
up duration was 89.5 ± 36.1 (range: 6.0–173.3) months. The baseline demographic and clinical
features of the study population are outlined in Table 1.
Clinical factors associated with long diagnostic delay in CD patients
We performed univariate and multivariate analyses to evaluate the association between the
clinical factors and long diagnostic delay. In CD patients with a diagnostic delay interval of
<18 months, compared to those with a diagnostic delay interval of18 months, univariate
analysis showed that older age at diagnosis (p = 0.006), concomitant UGI involvement
(p = 0.011), and disease behavior at diagnosis (p = 0.004) were associated with long diagnostic
delay. Subsequently, we performed a multivariate logistic regression analysis including all clini-
cally significant variables. This analysis identified the following variables as the independent
Table 1. Baseline demographics of study subjects (n = 1,047).
Demographic characteristics
Age at diagnosis (years)a 27.7 ± 12.3 (7.8–87.8)
Gender (male:female) 2.61:1 (757:290)
Family history of IBD (%) 23 (2.2)
History of prior abdominal surgery (%) 154 (14.7)
Disease location at diagnosis (%)b
Ileum only (L1) 239 (22.8)
Colon only (L2) 195 (18.6)
Ileocolon (L3) 613 (58.5)
Concomitant UGI disease (L4) 95 (9.1)
Disease behavior at diagnosis (%)b
Inﬂammatory (B1) 855 (81.7)
Stricturing (B2) 104 (9.9)
Penetrating (B3) 88 (8.4)
Concomitant perianal disease (P) 292 (27.9)
Medication (%)
5-ASA 1,025 (97.9)
Antibiotics 588 (56.2)
Oral corticosteroids 656 (62.7)
AZA/6-MP 748 (71.4)
MTX 12 (1.1)
Anti-TNFα 304 (29.0)
CD-related abdominal surgery (%) 228 (21.8)
Interval of diagnostic delay (%)
< 3 months 471 (45.0)
3–6 months 151 (14.4)
6–18 months 201 (19.2)
 18 months 224 (21.4)
Follow-up duration (months)a 89.5 ± 36.1 (6.0–173.3)
IBD, inﬂammatory bowel disease; UGI, upper gastrointestinal; 5-ASA, 5-aminosalicylic acid; AZA/6-MP,
azathioprine/6-mercaptopurine; MTX, methotrexate; anti-TNFα, anti-tumor necrosis factor α; CD, Crohn’s
disease.
aMean ± standard deviation.
bDisease location and behavior were determined according to the Montreal classiﬁcation.
doi:10.1371/journal.pone.0144390.t001
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risk factors for long diagnostic delay: older age at diagnosis (40 years) (odds ratio [OR] =
1.64; 95% CI, 1.11–2.42, p = 0.014), UGI disease (OR = 1.83; 95% CI, 1.14–2.93, p = 0.012), and
penetrating disease behavior (OR = 2.22; 95% CI, 1.38–3.57, p = 0.001) (Table 2).
Diagnostic delay was a predictive risk factor for intestinal complications
in CD patients
During longitudinal follow-up, disease-related complications developed in some CD patients
in this study. Intestinal stenosis, internal fistula, perianal fistula, abscess formation, and intesti-
nal perforation occurred in 262 (25.0%), 168 (16.0%), 390 (37.2%), 133 (12.7%), and 50 (4.8%)
Table 2. Clinical factors associated with long diagnostic delay ( 18 months) in Crohn’s disease.
Univariate analysis (Chi-square test) Multivariate analysis (Logistic
regression analysis)
Diagnostic delay  18 months
(N = 283)
Diagnostic delay < 18 months
(N = 978)
P
value
OR 95% CI P
value
Age at diagnosis (%)
 40 years 46 (29.7) 109 (70.3) 0.006 1.64 1.11–
2.42
0.014
< 40 years 178 (20.0) 714 (80.0) 1
(reference)
Gender
Female 72 (24.8) 218 (75.2) 0.094 1.30 0.94–
1.81
0.114
Male 152 (20.1) 605 (79.9) 1
(reference)
Family history of IBD (%)
Yes 8 (34.8) 15 (65.2) 0.113 1.99 0.82–
4.87
0.130
No 216 (21.1) 808 (78.9) 1
(reference)
Disease location at
diagnosis (%)a
Any ileal involvement 180 (21.1) 672 (78.9) 0.659 0.87 0.59–
1.27
0.462
No involvement of
ileum
44 (22.6) 151 (77.4) 1
(reference)
Concomitant UGI disease
(L4)
Yes 30 (31.6) 65 (68.4) 0.011 1.83 1.14–
2.93
0.012
No 194 (20.4) 758 (79.6) 1
(reference)
Disease behavior at
diagnosis (%)a
Inﬂammatory (B1) 170 (19.9) 685 (80.1) 0.004 1
(reference)
Stricturing (B2) 23 (22.1) 81 (77.9) 1.03 0.62–
1.70
0.917
Penetrating (B3) 31 (35.2) 57 (64.8) 2.22 1.38–
3.57
0.001
OR, Odds ratio; CI, conﬁdence interval; IBD, inﬂammatory bowel disease; UGI, upper gastrointestinal.
aDisease location and behavior were determined according to the Montreal classiﬁcation.
doi:10.1371/journal.pone.0144390.t002
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patients, respectively. To evaluate the impact of diagnostic delay on the clinical course in CD
patients, associations between clinical factors including the diagnostic delay interval and the
development of these complications were analyzed using univariate (Kaplan-Meier survival
model) and multivariate (Cox proportional hazards regression model) models.
In this study, long diagnostic delay (18 months) was independently associated with an
increased risk of intestinal stenosis (HR = 1.43; 95% CI, 1.07–1.93, p = 0.017). Moreover, a sig-
nificant association was observed between ileal involvement and the risk of intestinal stenosis
(HR = 1.54; 95% CI, 1.08–2.21, p = 0.017) (Table 3). Similarly, diagnostic delay and ileal
involvement were significantly associated with an increased risk of internal fistulas (HR = 1.62;
95% CI, 1.12–2.33, p = 0.011 and HR = 1.89; 95% CI, 1.17–3.06, p = 0.009, respectively)
(Table 4). In addition, long diagnostic delay (18 months) was independently predictive of
further development of perianal fistulas (HR = 1.38; 95% CI, 1.06–1.80, p = 0.016) (Table 5).
However, no significant association was observed between long diagnostic delay and other
complications such as abscess formation and intestinal perforation. Multivariate analysis
showed that no clinical factors were associated with a risk of abscess formation (S1 Table). A
significant association was observed between intestinal perforation and the male gender
(HR = 2.16, p = 0.047), but not between intestinal perforation and diagnostic delay (S2 Table).
As for the first CD-related abdominal surgery, no significant association was observed between
long diagnostic delay and the risk of abdominal surgery. Other factors such as ileal involvement
Table 3. Predictive clinical factors associated with the risk of intestinal stenosis in Korean patients with Crohn’s disease.
Univariate analysisa Multivariate analysisb
5-year cumulative rate (%) P value HR 95% CI P value
Age at diagnosis (%) 0.164
< 40 years 21.3 0.81 0.58–1.13 0.211
 40 years 27.5 1 (Ref)
Gender 0.176
Male 23.5 1.25 0.94–1.66 0.121
Female 19.1 1 (Ref)
Family history of IBD (%) 0.136
Yes 31.2 1.46 0.75–2.84 0.272
No 22.0 1 (Ref)
Disease location at diagnosis (%)c 0.013
Any ileal involvement 23.3 1.54 1.08–2.21 0.017
No involvement of ileum 17.5 1 (Ref)
Concomitant UGI disease (L4) 0.095
Yes 30.0 1.26 0.86–1.84 0.242
No 21.5 1 (Ref)
Interval of diagnostic delay (%) 0.017
< 3 months 21.2 1 (Ref)
3–6 months 19.2 0.87 0.58–1.29 0.477
6–18 months 21.0 0.97 0.69–1.36 0.846
 18 months 27.7 1.43 1.07–1.93 0.017
HR, hazard ratio; CI, conﬁdence interval; IBD, inﬂammatory bowel disease; UGI, upper gastrointestinal.
acalculated by a Kaplan-Meier survival model.
banalyzed by a multivariate Cox proportional hazards regression model.
cDisease location and behavior were determined according to the Montreal classiﬁcation.
doi:10.1371/journal.pone.0144390.t003
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(HR = 1.66, p = 0.014), stricturing (HR = 4.83, p< 0.001), and penetrating behavior
(HR = 5.99, p< 0.001) at diagnosis were associated with abdominal surgery (S3 Table).
Discussion
This nationwide CD cohort study in Korea showed that long diagnostic delay was significantly
associated with an increased risk of CD-related complications, such as intestinal stenosis, internal
fistulas, and perianal fistulas. Up to date, few studies have evaluated the impact of the diagnostic
delay of CD. A Swiss IBD cohort study reported that a long diagnostic delay was associated with
the further development of bowel stenosis and intestinal surgery [18]. These results may be closely
related to the sustained changes in the disease behavior of CD. Inflammatory disease behavior is
dominant during the early stages of CD, whereas patients tend to develop intestinal complications
such as strictures or fistulas as time passes [1,2]. In a study by Louis et al., disease behavior
changed in 45.9% of the CD patients over 10 years, and the change from inflammatory disease to
either stricturing or penetrating disease was the most common (27.1% and 29.4%, respectively)
[2]. Accordingly, it is speculated that a long diagnostic delay can represent a treatment gap that
causes disease progression to intestinal complications. Therefore, the diagnostic delay of CD is an
important issue because stricturing and penetrating disease behavior are both independent risk
factors for an unfavorable disease course, such as CD-related abdominal surgery [19,20].
Table 4. Predictive clinical factors associated with the risk of internal fistula in Korean patients with Crohn’s disease.
Univariate analysisa Multivariate analysisb
5-year cumulative rate (%) P value HR 95% CI P value
Age at diagnosis (%) 0.354
< 40 years 13.2 1.34 0.84–2.15 0.221
 40 years 12.7 1 (Ref)
Gender 0.211
Male 12.5 0.81 0.59–1.12 0.207
Female 14.9 1 (Ref)
Family history of IBD (%) 0.893
Yes 8.7 0.89 0.33–2.41 0.818
No 13.3 1 (Ref)
Disease location at diagnosis (%)c 0.009
Any ileal involvement 14.2 1.89 1.17–3.06 0.009
No involvement of ileum 8.5 1 (Ref)
Concomitant UGI disease (L4) 0.829
Yes 14.2 0.99 0.59–1.66 0.958
No 13.1 1 (Ref)
Interval of diagnostic delay (%) 0.040
< 3 months 11.7 1 (Ref)
3–6 months 12.5 1.01 0.63–1.64 0.957
6–18 months 10.2 0.92 0.59–1.43 0.720
 18 months 19.4 1.62 1.12–2.33 0.011
HR, hazard ratio; CI, conﬁdence interval; IBD, inﬂammatory bowel disease; UGI, upper gastrointestinal.
acalculated by a Kaplan-Meier survival model.
banalyzed by a multivariate Cox proportional hazards regression model.
cDisease location and behavior were determined according to the Montreal classiﬁcation.
doi:10.1371/journal.pone.0144390.t004
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In addition, in the last two decades, several studies reported that an early intensive treatment
with immunosuppressive agents or biologics showed better clinical outcomes than conventional
treatment in newly diagnosed CD patients [3,4]. In this regard, an international group of IBD
experts suggested that the concept of “early CD” be used in future clinical trials of CD [21]. They
defined early CD as a disease duration of18 months measured from the first diagnosis, with no
current/previous treatment with immunomodulators or biologics. Regarding the early use of dis-
ease-modifying agents, a trial, in which 133 moderate-severe CD patients were randomized to
receive either conventional treatment (step-up approach) or early combined treatment with aza-
thioprine and infliximab (top-down approach), reported that the combined immunosuppression
group (top-down) showed a greater effectiveness in clinical remission than the step-up group at
week 26 (60.0% vs. 35.9%, p = 0.0062) [3]. The impact of disease duration on treatment response
was also suggested in the PRECISE 2 study. This study reported that at week 26, the clinical
response rate with certolizumab pegol in CD patients with a diagnosis< 1 year (89.5%) was bet-
ter than that in those with a diagnosis 5 years (57.3%, p< 0.05) [4]. Furthermore, mucosal
healing, which is a promising surrogate end point for estimating disease course early, was
achieved more frequently in CD patients receiving scheduled infliximab treatment than in those
receiving episodic treatment for CD [22]. Taken together, the earlier CD was diagnosed from the
first CD-related symptoms, the earlier intensive treatment with disease-modifying drugs was
given to more CD patients, and the better was the disease course.
Table 5. Predictive clinical factors associated with the risk of perianal fistula in Korean patients with Crohn’s disease.
Univariate analysisa Multivariate analysisb
5-year cumulative rate (%) P value HR 95% CI P value
Age at diagnosis (%) < 0.001
< 40 years 39.1 3.15 2.05–4.86 < 0.001
 40 years 14.5 1 (Ref)
Gender 0.152
Male 37.0 1.12 0.89–1.41 0.339
Female 31.3 1 (Ref)
Family history of IBD (%) 0.136
Yes 47.8 1.46 0.82–2.61 0.198
No 35.1 1 (Ref)
Disease location at diagnosis (%)c 0.557
Any ileal involvement 35.8 1.03 0.80–1.34 0.808
No involvement of ileum 33.9 1 (Ref)
Concomitant UGI disease (L4) 0.359
Yes 40.1 1.12 0.80–1.56 0.523
No 35.0 1 (Ref)
Interval of diagnostic delay (%) 0.005
< 3 months 29.9 1 (Ref)
3–6 months 40.4 1.42 1.06–1.90 0.020
6–18 months 40.7 1.42 1.09–1.85 0.009
 18 months 39.0 1.38 1.06–1.80 0.016
HR, hazard ratio; CI, conﬁdence interval; IBD, inﬂammatory bowel disease; UGI, upper gastrointestinal.
acalculated by a Kaplan-Meier survival model.
banalyzed by a multivariate Cox proportional hazards regression model.
cDisease location and behavior were determined according to the Montreal classiﬁcation.
doi:10.1371/journal.pone.0144390.t005
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Interestingly, in this study, the impact of long diagnostic delay was observed on the occur-
rence of intestinal stenosis and internal fistula among the CD-related intestinal complications.
This phenomenon can be explained by the significant association between the occurrence of
intestinal stenosis and internal fistulas. Although the exact pathogenesis of developing an inter-
nal fistula is still unclear, a previous study showed that most internal fistulas occur within or
close (at the proximal end) to intestinal stenosis [23]. In addition, a significant association was
observed between a long diagnostic delay and occurrence of a perianal fistula. The occurrence of a
perianal fistula is a clinical predictive factor for disabling disease and disease-related surgery [24–
26] as well as a clinical outcome of an unfavorable disease course. These factors may cause this sig-
nificant association. On the other hand, there was no significant association between long diag-
nostic delay and the risk of abdominal surgery. These findings can be explained by several factors.
First, not all intestinal stenosis or fistulas require surgery. One researcher reported that the intesti-
nal fistula in itself is not regarded an indication for surgery, although it frequently occurs in CD
patients [27]. In general, fistulas accompanied by intestinal obstructions or abscesses, or which
cause intestinal malabsorption or communicate with the genitourinary tract are indications for
surgery. As for intestinal stenosis, abdominal surgery is only one of the therapeutic options. The
other options are anti-inflammatory medication and endoscopic balloon dilation [28,29]. Endo-
scopic dilation is an effective and safe alternative to surgical management, especially in short ste-
nosis [29]. Additionally, the present study did not include strictureplasty, a surgery used for
intestinal stenosis. Second, the cumulative rate of first CD-related abdominal surgery in Korean
CD patients was much lower than that inWestern patients [13,30]. The cumulative operation
rate could be influenced by differences of ethnicity, environment, or attitudes of physicians and
patients to surgery. Korean patients might be more unwilling to undergo intestinal resection than
Westerners, possibly because Korea is a country based on Confucian values [30,31]. These factors
can partially explain why we found no significant association between long diagnostic delay and
the risk of abdominal surgery in this study.
Our study also evaluated the clinical factors associated with a long diagnostic delay in CD
patients. Consequently, older age at diagnosis (40 years), concomitant UGI disease, and pen-
etrating disease behavior were identified as independent risk factors for long diagnostic delay
(18 months). Among them, an increased risk of diagnostic delay in older CD patients might
mainly depend on physician’s delay in diagnosing CD. Considering that the usual onset of CD
is at a younger age and there is still a relatively low prevalence of CD in Korea [13,32], it is spec-
ulated that physicians tend to not list CD in their differential diagnosis when they meet older
patients with CD symptoms. The increased risk of diagnostic delay in patients with concomi-
tant UGI disease may be partially explained by the fact that clinical symptoms of CD are simi-
lar to those with functional gastrointestinal disorders [33] or other UGI diseases including
peptic ulcer or dyspepsia. In particular, peptic ulcer is a significant concern for Koreans, in
whom the prevalence of Helicobacter pylori (H. pylori) infection for individuals older than 16
years is 59.6% [34].H. pylori has been reported to play a causal role in various conditions such
as peptic ulcer disease [35], gastroesophageal reflux disease [36], and functional dyspepsia [37].
Additionally, UGI disease in CD, namely, the Montreal L4 category also includes the involve-
ment in the proximal part of the small bowel as well as esophageal and gastroduodenal involve-
ment [15,38]. The diagnosis of small bowel CD, especially proximal small bowel, may be
challenging because of various nonspecific symptoms and limitations of detection with con-
ventional examinations [39]. Regarding the association between disease behavior and diagnos-
tic delay, the penetrating behavior may be considered to be a consequence of long diagnostic
delay. CD patients with long diagnostic delay may tend to develop penetrating disease behavior
because of the sustained progression of the disease behavior over time [1,2]. As for this issue, a
few studies have evaluated the factors associated with the diagnostic delay of CD. In a Swiss
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IBD cohort study by Vavricka et al., younger age at first diagnosis (<40 years) and ileal
involvement were significantly associated with a long diagnostic delay (24 months) [8]. A
French cohort study reported that no medical and socioeconomic characteristics affected the
long diagnostic delay of CD [9]. A recent study in Chinese CD patients indicated older age at
diagnosis (> 40 years), a basic education status, and no family history of CD were risk factors
for a long diagnostic delay [10]. The results of these studies are not comparable to our results.
This discrepancy may be influenced by differences in the epidemiologic and clinical features of
CD and genetic susceptibility to CD according to patient ethnicity [13,30,32,40,41]. Further
large studies across multiple ethnic groups are warranted to obtain convincing results related
to clinical factors associated with a long diagnostic delay in CD patients.
Our study has several limitations. First, because of the retrospective design of this study, it
may be subject to recall bias for the first CD-related symptoms and their onset. In addition, since
some symptoms of CD are similar to those of IBS, it was difficult to determine the exact duration
of the diagnostic delay (from the first symptoms to diagnosis) in some cases. Additionally, avail-
able data retrieved from the CONNECT study, a multicenter retrospective cohort, did not include
the detailed information, such as the different diagnostic intervals (patient-related or physician-
related delay) or howmany doctors they had visited. Thus, in the present study, we assessed and
analyzed clinical data including only the “overall diagnostic delay” (the time interval from the
onset of the first symptoms to the establishment of the CD diagnosis). Second, our study lacks
some important information on environmental and socioeconomic factors such as smoking hab-
its, intake of non-steroidal anti-inflammatory drugs or oral contraceptives, and socioeconomic or
educational status of the patients. In particular, previous studies have determined the harmful
effects of smoking habits on disease course and the risk of recurrence or reoperation in CD
patients [42–44]. Moreover, this study was not a population-based cohort study. However, con-
sidering that the majority of Korean CD patients are diagnosed and managed in tertiary medical
centers in Korea [32], this CD cohort, including patients from 32 hospitals nationwide, may con-
siderably reflect the real population of CD patients in Korea. Furthermore, since all patients were
diagnosed and treated by IBD specialists, clinical data in this cohort are quite convincing.
In conclusion, this study demonstrated that a long diagnostic delay is significantly associ-
ated with an increased risk of CD-related complications such as intestinal stenosis, internal fis-
tulas, and perianal fistulas. Moreover, older age at diagnosis (40 years), concomitant UGI
involvement, and penetrating disease behavior are closely associated with diagnostic delay in
CD patients. On the basis of these results, reducing the diagnostic delay of CD may reduce the
occurrence of many disabling complications associated with CD. Thus, our results suggest that
physicians should make particular efforts to increase the rate of early diagnosis and raise public
awareness about the warning symptoms of CD.
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